Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma

Renal cell carcinoma (RCC) is a highly vascularized and immunogenic tumor, being an ideal candidate for checkpoint blockade-based immunotherapy. Accordingly, checkpoint inhibitors have demonstrated clinical efficacy in patients with metastatic RCC (mRCC). Sex-specific differences in cancer immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tulchiner, Gennadi, Pichler, Renate, Ulmer, Hanno, Staudacher, Nina, Lindner, Andrea Katharina, Brunner, Andrea, Zelger, Bettina, Steinkohl, Fabian, Aigner, Friedrich, Horninger, Wolfgang, Thurnher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423679/
https://www.ncbi.nlm.nih.gov/pubmed/33646368
http://dx.doi.org/10.1007/s00262-021-02882-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423679/
https://www.ncbi.nlm.nih.gov/pubmed/33646368
http://dx.doi.org/10.1007/s00262-021-02882-y

Ejemplares similares